• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP ANTI-TG (ATG) ASSAY; ANTI-TG (ATG) IMMUNOASSAY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SIEMENS HEALTHCARE DIAGNOSTICS, INC. ADVIA CENTAUR XP ANTI-TG (ATG) ASSAY; ANTI-TG (ATG) IMMUNOASSAY Back to Search Results
Model Number N/A
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 05/22/2018
Event Type  malfunction  
Manufacturer Narrative
The cause for the false negative advia centaur xp anti-tg (atg) result is unknown.The customer's quality control (qc) was within acceptable ranges.Siemens is investigating.The instruction for use (ifu) under the interpretation of results section states the following: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings.".
 
Event Description
A false negative advia centaur xp anti-tg (atg) result was obtained on a patient sample when tested with reagent lot 085298.The low atg result was considered discordant compared to an initial positive result with reagent lot 085295.The initial positive result was in agreement with the clinical picture of the patient, and the result reported to the physician.Patient treatment was not altered or prescribed or adverse health consequences due to the discordant advia centaur xp atg result.
 
Manufacturer Narrative
Siemens filed mdr on 06/20/2018 for a false negative advia centaur xp anti-tg (atg) patient result when tested with reagent lot 085298.06/27/2018 - additional information: the cause for the false negative advia centaur xp anti-tg (atg) patient result when tested with reagent lot 085298 is unknown, and may be attributed to sample preparation and sample handling.The patient sample is not available for further investigation.No conclusion can be drawn.The instruction for use (ifu) under the interpretation of results section states the following: "results of this assay should always be interpreted in conjunction with patient's medical history, clinical presentation and other findings." the instrument is performing within specifications.No further evaluation of the device is required.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ADVIA CENTAUR XP ANTI-TG (ATG) ASSAY
Type of Device
ANTI-TG (ATG) IMMUNOASSAY
Manufacturer (Section D)
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
511 benedict avenue
tarrytown NY 10591 5097
MDR Report Key7620572
MDR Text Key112459677
Report Number1219913-2018-00176
Device Sequence Number1
Product Code JZO
UDI-Device Identifier00630414579221
UDI-Public00630414579221
Combination Product (y/n)N
PMA/PMN Number
K012777
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 07/03/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/20/2018
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date10/11/2018
Device Model NumberN/A
Device Catalogue Number10492399
Device Lot Number085298
Was Device Available for Evaluation? No
Was the Report Sent to FDA? No
Date Manufacturer Received06/27/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Age47 YR
-
-